WHO Approves Clinical Trials for Two New Ebola Vaccines
The candidates are being developed by Oxford, the Serum Institute of India and Moderna as health workers battle an outbreak that has killed more than 5,300 people.
- On Wednesday, the World Health Organization approved clinical trials for two new vaccines targeting the Bundibugyo virus to combat the ongoing Ebola outbreak in the Democratic Republic of Congo.
- The current epidemic, which began in the DRC in May, has infected more than 10,000 people with a fatality rate of more than 50 percent, caused by the rare Bundibugyo virus for which no vaccine existed.
- WHO chief Tedros Adhanom Ghebreyesus announced the trials will feature ChAdOx1 BDBV, developed by the University of Oxford and the Serum Institute of India, and Moderna's mRNA-1469, replacing the ineffective Ervebo vaccine.
- Nations including Ghana and the United States introduced travel restrictions on DRC travelers, though Tedros condemned the measures, recommending countries lift them to avoid creating disincentives for transparency.
- The Africa Centres for Disease Control and Prevention reported on Monday that the epidemic has killed more than 5,300 people, as the DRC's National Institute for Biomedical Research leads the trial with international partner support.
22 Articles
22 Articles
The organization recommended incorporating two new candidates targeted against a strain for which there is still no approved vaccine; one uses messenger RNA and the other was developed by the University of Oxford
Reformatorisch Dagblad
The World Health Organization (WHO) has granted approval to conduct clinical trials of two new Ebola vaccines. These are the first vaccines specifically developed against the bundibugyo variant of the virus, which has already caused thousands of deaths in the Democratic Republic of Congo in recent months.
Punch Newspapers
WHO approves clinical trials on two new Ebola vaccines
The World Health Organisation has approved clinical trials for two new Ebola vaccines to combat an outbreak in Africa that has killed over 5,300 people. Read More: https://punchng.com/who-approves-clinical-trials-on-two-new-ebola-vaccines/
The World Health Organization (WHO) recommended, on Wednesday, the expansion of clinical trials for two new Ebola vaccines in the context of the epidemic affecting the Democratic Republic of the Congo. WHO: 1 in 4 adolescents in the world does not practice any physical activity See also: Woman dies 40 days after suspected bite of poisonous spider in Italy; police investigates possible medical negligence — Today, WHO expert groups recommend the i…
Coverage Details
Bias Distribution
- 62% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
